Cargando…
Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling
BACKGROUND: Marfan syndrome (MFS) is caused by mutations in the gene encoding fibrillin‐1 (FBN1); however, the mechanisms through which fibrillin‐1 deficiency causes MFS‐associated aortopathy are uncertain. Recently, attention was focused on the hypothesis that MFS‐associated aortopathy is caused by...
Autores principales: | Wei, Hao, Hu, Jie Hong, Angelov, Stoyan N., Fox, Kate, Yan, James, Enstrom, Rachel, Smith, Alexandra, Dichek, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523644/ https://www.ncbi.nlm.nih.gov/pubmed/28119285 http://dx.doi.org/10.1161/JAHA.116.004968 |
Ejemplares similares
-
Ventricular‐Vascular Coupling in Marfan and Non‐Marfan Aortopathies
por: Loeper, Farina, et al.
Publicado: (2016) -
Hyperuricaemia Does Not Interfere with Aortopathy in a Murine Model of Marfan Syndrome
por: Rodríguez-Rovira, Isaac, et al.
Publicado: (2023) -
Thoracic aortopathy in Marfan syndrome overlaps with mechanisms seen in bicuspid aortic valve disease
por: Grewal, Nimrat, et al.
Publicado: (2023) -
Transforming growth factor serum concentrations in patients with proven non-syndromic aortopathy
por: Karalko, Mikita, et al.
Publicado: (2022) -
Specific miRNA and Gene Deregulation Characterize the Increased Angiogenic Remodeling of Thoracic Aneurysmatic Aortopathy in Marfan Syndrome
por: D’Amico, Federico, et al.
Publicado: (2020)